Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot

Clinical trial NCT05999656 · UNKNOWN

Trial details

NCT number: NCT05999656
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Refractory Diabetic Foot Human Cord Blood-derived Mononuclear Cells Efficacy Safety Local Injection

Start date: 2023-05-28
Primary completion: 2024-05-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.